180 related articles for article (PubMed ID: 18182454)
1. Reduced apolipoprotein E-rich high-density lipoprotein level at birth is restored to the normal range in patients with familial hypercholesterolemia in the first year of life.
Nagasaka H; Miida T; Hirano K; Ota A; Yorifuji T; Takatani T; Tsukahara H; Takayanagi M; Hui SP; Kobayashi K; Chiba H
J Clin Endocrinol Metab; 2008 Mar; 93(3):779-83. PubMed ID: 18182454
[TBL] [Abstract][Full Text] [Related]
2. Serum apolipoproteins in heterozygous familial hypercholesterolemia.
Kajinami K; Mabuchi H; Koizumi J; Takeda R
Clin Chim Acta; 1992 Oct; 211(1-2):93-9. PubMed ID: 1468157
[TBL] [Abstract][Full Text] [Related]
3. HDL cholesterol levels in patients with molecularly defined familial hypercholesterolemia.
Miltiadous G; Cariolou MA; Elisaf M
Ann Clin Lab Sci; 2002; 32(1):50-4. PubMed ID: 11848618
[TBL] [Abstract][Full Text] [Related]
4. Determinants of lipid level variability in French-Canadian children with familial hypercholesterolemia.
Lambert M; Assouline L; Feoli-Fonseca JC; Brun N; Delvin EE; Lévy E
Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):979-84. PubMed ID: 11397707
[TBL] [Abstract][Full Text] [Related]
5. Influence of HDL cholesterol on preclinical carotid atherosclerosis in familial hypercholesterolemia.
Junyent M; Cofán M; Núñez I; Gilabert R; Zambón D; Ros E
Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1107-13. PubMed ID: 16556855
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol metabolism in normal and heterozygous familial hypercholesterolemic newborns.
Vuorio AF; Miettinen TA; Turtola H; Oksanen H; Gylling H
J Lab Clin Med; 2002 Jul; 140(1):35-42. PubMed ID: 12080326
[TBL] [Abstract][Full Text] [Related]
7. Differences in the phenotype between children with familial defective apolipoprotein B-100 and familial hypercholesterolemia.
Pimstone SN; Defesche JC; Clee SM; Bakker HD; Hayden MR; Kastelein JJ
Arterioscler Thromb Vasc Biol; 1997 May; 17(5):826-33. PubMed ID: 9157944
[TBL] [Abstract][Full Text] [Related]
8. Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations.
Torres AL; Moorjani S; Vohl MC; Gagné C; Lamarche B; Brun LD; Lupien PJ; Després JP
Atherosclerosis; 1996 Sep; 126(1):163-71. PubMed ID: 8879444
[TBL] [Abstract][Full Text] [Related]
9. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
10. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population.
Assouline L; Levy E; Feoli-Fonseca JC; Godbout C; Lambert M
Pediatrics; 1995 Aug; 96(2 Pt 1):239-46. PubMed ID: 7630677
[TBL] [Abstract][Full Text] [Related]
11. Effect of apolipoprotein E genotype on lipid levels and response to diet in familial hypercholesterolemia.
Carmena-Ramón R; Real JT; Ascaso JF; Ordovás JM; Carmena R
Nutr Metab Cardiovasc Dis; 2000 Feb; 10(1):7-13. PubMed ID: 10812582
[TBL] [Abstract][Full Text] [Related]
12. Neonatal diagnosis of familial hypercholesterolemia in newborns born to a parent with a molecularly defined heterozygous familial hypercholesterolemia.
Vuorio AF; Turtola H; Kontula K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3332-7. PubMed ID: 9409330
[TBL] [Abstract][Full Text] [Related]
13. Changes in ultracentrifugally separated plasma lipoprotein subfractions in patients with polygenic hypercholesterolemia, familial combined hyperlipoproteinemia, and familial hypercholesterolemia after treatment with atorvastatin.
Homma K; Homma Y; Yoshida T; Ozawa H; Shiina Y; Wakino S; Hayashi K; Itoh H; Hori S
J Clin Lipidol; 2015; 9(2):210-6. PubMed ID: 25911077
[TBL] [Abstract][Full Text] [Related]
14. Pediatric implications of heterozygous familial hypercholesterolemia. Screening and dietary treatment.
Kwiterovich PO
Arteriosclerosis; 1989; 9(1 Suppl):I111-20. PubMed ID: 2563219
[TBL] [Abstract][Full Text] [Related]
15. Transfer of lipids to high-density lipoprotein (HDL) is altered in patients with familial hypercholesterolemia.
Martinez LR; Santos RD; Miname MH; Deus DF; Lima ES; Maranhão RC
Metabolism; 2013 Aug; 62(8):1061-4. PubMed ID: 23540443
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of lipoprotein (a) in children with familial hypercholesterolemia.
Widhalm K; Genser D
Wien Klin Wochenschr; 1994; 106(7):197-200. PubMed ID: 8197753
[TBL] [Abstract][Full Text] [Related]
17. Familial hypercholesterolemia and apolipoprotein E4.
Eto M; Watanabe K; Chonan N; Ishii K
Atherosclerosis; 1988 Aug; 72(2-3):123-8. PubMed ID: 3214464
[TBL] [Abstract][Full Text] [Related]
18. Sex differences in cholesterol levels from birth to 19 years of age may lead to increased cholesterol burden in females with FH.
Holven KB; Narverud I; van Lennep JR; Versmissen J; Øyri LKL; Galema-Boers A; Langslet G; Ulven SM; Veierød MB; Retterstøl K; Bogsrud MP
J Clin Lipidol; 2018; 12(3):748-755.e2. PubMed ID: 29609857
[TBL] [Abstract][Full Text] [Related]
19. Maternal inheritance does not predict cholesterol levels in children with familial hypercholesterolemia.
Narverud I; van Lennep JR; Christensen JJ; Versmissen J; Gran JM; Iversen PO; Aukrust P; Halvorsen B; Ueland T; Ulven SM; Ose L; Veierød MB; Sijbrands E; Retterstøl K; Holven KB
Atherosclerosis; 2015 Nov; 243(1):155-60. PubMed ID: 26386212
[TBL] [Abstract][Full Text] [Related]
20. High density lipoprotein-cholesterol changes in children with high cholesterol levels at birth.
Bastida S; Sánchez-Muniz FJ; Cuena R; Perea S; Aragonés A
Eur J Pediatr; 2002 Feb; 161(2):94-8. PubMed ID: 11954759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
